Wilmington, DE -- (SBWIRE) -- 09/12/2013 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding JA Solar Holdings Co., Ltd. (NASDAQ:JASO) and Synta Pharmaceuticals Corp. (NASDAQ:SNTA).
JA Solar Holdings Co., Ltd. (NASDAQ:JASO) a company that through its subsidiaries, engages in the design, development, production, marketing, and sale of solar power products based on crystalline silicon technologies closed down in its previous session (-0.22%) on 1,990,175 shares traded after JASO Won Domestic Order. JA Solar Holdings Co., Ltd. (NASDAQ:JASO) is currently down (-22.98%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about JA Solar Holdings Co., Ltd. (NASDAQ:JASO)
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) a biopharmaceutical company that focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases closed up in its previous session (+4.17%) on 1,240,846 shares traded after Synta Announced Launch of Proprietary Small Molecule Hsp90-inhibitor Drug Conjugate Platform. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) is currently up (+83.24%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)